Inogen said regulators have cleared its SIMEOX 200 Airway Clearance Device to be used by U.S. patients with chronic respiratory diseases. The medical technology company said Monday that the Food ...
clearance for the SIMEOX 200 Airway Clearance Device, expanding the company’s ability to market and meet the various needs of patients with chronic respiratory diseases in the U.S. SIMEOX 200 is ...
The US Food and Drug Administration (FDA) has granted 510(k) clearance for Inogen’s SIMEOX 200 Airway Clearance Device for individuals suffering from chronic respiratory conditions. The SIMEOX ...
Inogen, Inc. INGN recently announced the FDA 510(k) clearance for the SIMEOX 200 Airway Clearance Device. The clearance is likely to expand INGN’s ability to market the device and meet the ...
“By tapping into our well-established network of healthcare providers, B2B partners, and our Direct-to-Patient team, we aim to bring this next-generation airway clearance device to patients ...
clearance for the SIMEOX 200 Airway Clearance Device, designed to help patients with chronic lung diseases associated with mucus hypersecretion and mucus retention. The device promotes and ...